A. GÖKÇAY CANPOLAT Et Al. , "Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis," ETA 2019 , 2019
GÖKÇAY CANPOLAT, A. Et Al. 2019. Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis. ETA 2019 .
GÖKÇAY CANPOLAT, A., CİNEL, M., SAK, S., TAŞKALDIRAN, I., KORKMAZ, H., CANLAR, Ş., ... DEMİR, Ö.(2019). Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis . ETA 2019
GÖKÇAY CANPOLAT, ASENA Et Al. "Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis," ETA 2019, 2019
GÖKÇAY CANPOLAT, ASENA G. Et Al. "Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis." ETA 2019 , 2019
GÖKÇAY CANPOLAT, A. Et Al. (2019) . "Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis." ETA 2019 .
@conferencepaper{conferencepaper, author={ASENA GÖKÇAY CANPOLAT Et Al. }, title={Tamoxifen citrate could be the drug of choice on the long term follow up of the Riedel thyroiditis}, congress name={ETA 2019}, city={}, country={}, year={2019}}